225 related articles for article (PubMed ID: 16299104)
1. The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues.
Havt A; Schally AV; Halmos G; Varga JL; Toller GL; Horvath JE; Szepeshazi K; Köster F; Kovitz K; Groot K; Zarandi M; Kanashiro CA
Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17424-9. PubMed ID: 16299104
[TBL] [Abstract][Full Text] [Related]
2. Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer.
Halmos G; Schally AV; Czompoly T; Krupa M; Varga JL; Rekasi Z
J Clin Endocrinol Metab; 2002 Oct; 87(10):4707-14. PubMed ID: 12364462
[TBL] [Abstract][Full Text] [Related]
3. Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours.
Freddi S; Arnaldi G; Fazioli F; Scarpelli M; Appolloni G; Mancini T; Kola B; Bertagna X; Mantero F; Collu R; Boscaro M
Clin Endocrinol (Oxf); 2005 May; 62(5):533-8. PubMed ID: 15853821
[TBL] [Abstract][Full Text] [Related]
4. Expression of Growth Hormone-Releasing Hormone and Its Receptor Splice Variants in Primary Human Endometrial Carcinomas: Novel Therapeutic Approaches.
Szabo Z; Juhasz E; Schally AV; Dezso B; Huga S; Hernadi Z; Halmos G; Kiss C
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566020
[TBL] [Abstract][Full Text] [Related]
5. Prognosis in human glioblastoma based on expression of ligand growth hormone-releasing hormone, pituitary-type growth hormone-releasing hormone receptor, its splicing variant receptors, EGF receptor and PTEN genes.
Mezey G; Treszl A; Schally AV; Block NL; Vízkeleti L; Juhász A; Klekner A; Nagy J; Balázs M; Halmos G; Bognár L
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1641-9. PubMed ID: 24878932
[TBL] [Abstract][Full Text] [Related]
6. Expression of growth hormone-releasing hormone receptor splice variant 1 in primary human melanomas.
Chatzistamou I; Volakaki AA; Schally AV; Kiaris H; Kittas C
Regul Pept; 2008 Apr; 147(1-3):33-6. PubMed ID: 18255167
[TBL] [Abstract][Full Text] [Related]
7. The effect of a novel antagonist of growth hormone releasing hormone on cell proliferation and on the key cell signaling pathways in nine different breast cancer cell lines.
Pozsgai E; Schally AV; Hocsak E; Zarandi M; Rick F; Bellyei S
Int J Oncol; 2011 Oct; 39(4):1025-32. PubMed ID: 21701777
[TBL] [Abstract][Full Text] [Related]
8. Expression of growth hormone-releasing hormone (GHRH) and splice variant of GHRH receptors in normal mouse tissues.
Christodoulou C; Schally AV; Chatzistamou I; Kondi-Pafiti A; Lamnissou K; Kouloheri S; Kalofoutis A; Kiaris H
Regul Pept; 2006 Sep; 136(1-3):105-8. PubMed ID: 16781787
[TBL] [Abstract][Full Text] [Related]
9. Activation of mitogen-activated protein kinases by a splice variant of GHRH receptor.
Barabutis N; Siejka A; Schally AV; Block NL; Cai R; Varga JL
J Mol Endocrinol; 2010 Feb; 44(2):127-34. PubMed ID: 19897610
[TBL] [Abstract][Full Text] [Related]
10. The expression of growth hormone-releasing hormone (GHRH) and its receptor splice variants in human breast cancer lines; the evaluation of signaling mechanisms in the stimulation of cell proliferation.
Garcia-Fernandez MO; Schally AV; Varga JL; Groot K; Busto R
Breast Cancer Res Treat; 2003 Jan; 77(1):15-26. PubMed ID: 12602901
[TBL] [Abstract][Full Text] [Related]
11. The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas.
Busto R; Schally AV; Varga JL; Garcia-Fernandez MO; Groot K; Armatis P; Szepeshazi K
Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11866-71. PubMed ID: 12186980
[TBL] [Abstract][Full Text] [Related]
12. Expression of Receptors for Pituitary-Type Growth Hormone-Releasing Hormone (pGHRH-R) in Human Papillary Thyroid Cancer Cells: Effects of GHRH Antagonists on Matrix Metalloproteinase-2.
Catanuto P; Tashiro J; Rick FG; Sanchez P; Solorzano CC; Glassberg MK; Block NL; Lew JI; Elliot SJ; Schally AV
Horm Cancer; 2015 Jun; 6(2-3):100-6. PubMed ID: 25752763
[TBL] [Abstract][Full Text] [Related]
13. Cellular mechanisms of growth inhibition of human endometrial cancer cell line by an antagonist of growth hormone-releasing hormone.
Zhao L; Yano T; Osuga Y; Nakagawa S; Oishi H; Wada-Hiraike O; Tang X; Yano N; Kugu K; Schally AV; Taketani Y
Int J Oncol; 2008 Mar; 32(3):593-601. PubMed ID: 18292936
[TBL] [Abstract][Full Text] [Related]
14. Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers.
Plonowski A; Schally AV; Busto R; Krupa M; Varga JL; Halmos G
Peptides; 2002 Jun; 23(6):1127-33. PubMed ID: 12126741
[TBL] [Abstract][Full Text] [Related]
15. Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH.
Schally AV; Wang H; He J; Cai R; Sha W; Popovics P; Perez R; Vidaurre I; Zhang X
Proc Natl Acad Sci U S A; 2018 Nov; 115(47):12028-12033. PubMed ID: 30373845
[TBL] [Abstract][Full Text] [Related]
16. Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.
Rekasi Z; Czompoly T; Schally AV; Halmos G
Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10561-6. PubMed ID: 10962031
[TBL] [Abstract][Full Text] [Related]
17. Development of a polyclonal antiserum for the detection of the isoforms of the receptors for human growth hormone-releasing hormone on tumors.
Toller GL; Horvath JE; Schally AV; Halmos G; Varga JL; Groot K; Chism D; Zarandi M
Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15160-5. PubMed ID: 15469915
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of GHRH and its receptor splice variant 1 in primary human breast cancers.
Chatzistamou I; Schally AV; Kiaris H; Politi E; Varga J; Kanellis G; Kalofoutis A; Pafiti A; Koutselini H
Eur J Endocrinol; 2004 Sep; 151(3):391-6. PubMed ID: 15362970
[TBL] [Abstract][Full Text] [Related]
19. Expression and possible implication of growth hormone-releasing hormone receptor splice variant 1 in endometriosis.
Fu L; Osuga Y; Yano T; Takemura Y; Morimoto C; Hirota Y; Schally AV; Taketani Y
Fertil Steril; 2009 Jul; 92(1):47-53. PubMed ID: 18684444
[TBL] [Abstract][Full Text] [Related]
20. Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function.
Szalontay L; Schally AV; Popovics P; Vidaurre I; Krishan A; Zarandi M; Cai RZ; Klukovits A; Block NL; Rick FG
Cell Cycle; 2014; 13(17):2790-7. PubMed ID: 25486366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
